Aliskiren for Immunoglobulin A (IgA) Nephropathy

NCT00870493 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

IgA Nephropathy

Interventions

DRUG: Aliskiren
DRUG: Placebo

Sponsor

Chinese University of Hong Kong